Truist Financial started coverage on shares of Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) in a research report issued on Monday, Briefing.com reports. The firm set a “buy” rating and a $22.00 price target on the stock. Truist Financial’s target price points to a potential upside of 24.43% from the stock’s current price.
Guardian Pharmacy Services Stock Up 1.7 %
Shares of NYSE GRDN opened at $17.68 on Monday. Guardian Pharmacy Services has a twelve month low of $14.16 and a twelve month high of $20.10.
Insider Buying and Selling
In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. bought 35,714 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The stock was purchased at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the purchase, the director now directly owns 35,714 shares in the company, valued at $499,996. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Institutional Investors Weigh In On Guardian Pharmacy Services
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Recommended Stories
- Five stocks we like better than Guardian Pharmacy Services
- What is Put Option Volume?
- Morgan Stanley Touches New High – Can it Mover Higher?
- Election Stocks: How Elections Affect the Stock Market
- Boeing Stock: Should You Buy, Sell, or Hold Ahead of Earnings
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Is Uber the Real Winner After Tesla’s ‘We, Robot’ Flop?
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.